Guan Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Systematic Review

Clinical Practice

Epidermal Growth Factor Receptor

Top Venues

Journal of medicinal chemistry

Translational neurodegeneration

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Zhang, Yongya Wu, Shuai Zhang, Wenmo Yao, Faqian Bu, Aoxue Wang, Xiuying Hu, Guan Wang
Appraising the quality standard of clinical practice guidelines related to central venous catheter-related thrombosis prevention: a systematic review of clinical practice guidelines. BMJ open 14 (3) (2024)
Aoxue Wang, Wen Shuai, Chengyong Wu, Junping Pei, Panpan Yang, Xin Wang, Shutong Li, Jiaxi Liu, Yu-Xi Wang, Guan Wang, Liang Ouyang
Design, Synthesis, and Biological Evaluation of Dual Inhibitors of EGFR L858R/T790M /ACK1 to Overcome Osimertinib Resistance in Nonsmall Cell Lung Cancers. Journal of medicinal chemistry (2024)
Wen Shuai, Huan Xiao, Panpan Yang, Yiwen Zhang, Faqian Bu, Yongya Wu, Qiu Sun, Guan Wang, Liang Ouyang
Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors. Journal of medicinal chemistry 67 (8) (2024)
Jing Zhang, Yongya Wu, Shuai Zhang, Wenmo Yao, Faqian Bu, Aoxue Wang, Xiuying Hu, Guan Wang
Appraising the quality standard of clinical practice guidelines related to central venous catheter-related thrombosis prevention: a systematic review of clinical practice guidelines. BMJ open 14 (3) (2024)
Jing Zhang, Yongya Wu, Shuai Zhang, Wenmo Yao, Faqian Bu, Aoxue Wang, Xiuying Hu, Guan Wang
Appraising the quality standard of clinical practice guidelines related to central venous catheter-related thrombosis prevention: a systematic review of clinical practice guidelines. BMJ open 14 (3) (2024)
Aoxue Wang, Wen Shuai, Chengyong Wu, Junping Pei, Panpan Yang, Xin Wang, Shutong Li, Jiaxi Liu, Yu-Xi Wang, Guan Wang, Liang Ouyang
Design, Synthesis, and Biological Evaluation of Dual Inhibitors of EGFR L858R/T790M /ACK1 to Overcome Osimertinib Resistance in Nonsmall Cell Lung Cancers. Journal of medicinal chemistry 67 (4) (2024)
Aoxue Wang, Wen Shuai, Chengyong Wu, Junping Pei, Panpan Yang, Xin Wang, Shutong Li, Jiaxi Liu, Yu-Xi Wang, Guan Wang, Liang Ouyang
Design, Synthesis, and Biological Evaluation of Dual Inhibitors of EGFR L858R/T790M /ACK1 to Overcome Osimertinib Resistance in Nonsmall Cell Lung Cancers. Journal of medicinal chemistry 67 (4) (2024)
Jing Zhang, Yongya Wu, Shuai Zhang, Wenmo Yao, Faqian Bu, Aoxue Wang, Xiuying Hu, Guan Wang
Appraising the quality standard of clinical practice guidelines related to central venous catheter-related thrombosis prevention: a systematic review of clinical practice guidelines. BMJ open 14 (3) (2024)
Wen Shuai, Huan Xiao, Panpan Yang, Yiwen Zhang, Faqian Bu, Yongya Wu, Qiu Sun, Guan Wang, Liang Ouyang
Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors. Journal of medicinal chemistry (2024)
Yi Lu, Fa-Qian Bu, Fang Wang, Li Liu, Shuai Zhang, Guan Wang, Xiu-Ying Hu
Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction. Translational neurodegeneration 12 (1) (2023)
Wen Shuai, Faqian Bu, Yumeng Zhu, Yongya Wu, Huan Xiao, Xiaoli Pan, Jifa Zhang, Qiu Sun, Guan Wang, Liang Ouyang
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry (2023)
Wen Shuai, Faqian Bu, Yumeng Zhu, Yongya Wu, Huan Xiao, Xiaoli Pan, Jifa Zhang, Qiu Sun, Guan Wang, Liang Ouyang
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry 66 (2) (2023)
Junping Pei, Guan Wang, Aoxue Wang, Chengyong Wu, Xiaoli Pan, Wen Shuai, Faqian Bu, Yumeng Zhu, Yu-Xi Wang, Liang Ouyang, Weimin Li
Design, Synthesis, and Antitumor Activity of Potent and Selective EGFR L858R/T790M Inhibitors and Identification of a Combination Therapy to Overcome Acquired Resistance in Models of Non-small-cell Lung Cancer. Journal of medicinal chemistry (2023)
Wen Shuai, Faqian Bu, Yumeng Zhu, Yongya Wu, Huan Xiao, Xiaoli Pan, Jifa Zhang, Qiu Sun, Guan Wang, Liang Ouyang
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry 66 (2) (2023)
Yi Lu, Fa-Qian Bu, Fang Wang, Li Liu, Shuai Zhang, Guan Wang, Xiu-Ying Hu
Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction. Translational neurodegeneration 12 (1) (2023)
Wen Shuai, Faqian Bu, Yumeng Zhu, Yongya Wu, Huan Xiao, Xiaoli Pan, Jifa Zhang, Qiu Sun, Guan Wang, Liang Ouyang
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry 66 (2) (2023)
Chufeng Zhang, Min Zhao, Guan Wang, Yong Li
Recent Progress on Microtubule Degradation Agents. Journal of medicinal chemistry (2023)
Yi Lu, Fa-Qian Bu, Fang Wang, Li Liu, Shuai Zhang, Guan Wang, Xiu-Ying Hu
Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction. Translational neurodegeneration 12 (1) (2023)
Zehao Su, Chenyu Tian, Guan Wang, Jingjing Guo, Xiaoyan Yang
Study of the Effect of Intestinal Microbes on Obesity: A Bibliometric Analysis. Nutrients 15 (14) (2023)
Jun Wang, Fang Wang, Hongxiu Chen, Li Liu, Shuai Zhang, Wenjing Luo, Guan Wang, Xiuying Hu
Comparison of the Effects of Intermittent Energy Restriction and Continuous Energy Restriction among Adults with Overweight or Obesity: An Overview of Systematic Reviews and Meta-Analyses. Nutrients 14 (11) (2022)
Yumeng Zhu, Wen Shuai, Min Zhao, Xiaoli Pan, Junping Pei, Yongya Wu, Faqian Bu, Aoxue Wang, Liang Ouyang, Guan Wang
Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases. Journal of medicinal chemistry 65 (5) (2022)
Junping Pei, Xiaoli Pan, Aoxue Wang, Wen Shuai, Faqian Bu, Pan Tang, Shuai Zhang, Yiwen Zhang, Guan Wang, Liang Ouyang
Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy. Chemical communications (Cambridge, England) 57 (97) (2021)
Yang Li, Gaoxia Yang, Jifa Zhang, Pan Tang, Chengcan Yang, Guan Wang, Juncheng Chen, Jie Liu, Lan Zhang, Liang Ouyang
Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer. Journal of medicinal chemistry 64 (16) (2021)
Aoxue Wang, Junping Pei, Wen Shuai, Congcong Lin, Lu Feng, Yu-Xi Wang, Feng Lin, Liang Ouyang, Guan Wang
Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers. Journal of medicinal chemistry 64 (22) (2021)
Jin Zhang, Ling Zou, Danfeng Shi, Jie Liu, Jifa Zhang, Rongyan Zhao, Guan Wang, Lan Zhang, Liang Ouyang, Bo Liu
Structure-Guided Design of a Small-Molecule Activator of Sirtuin-3 that Modulates Autophagy in Triple Negative Breast Cancer. Journal of medicinal chemistry 64 (19) (2021)
Jifa Zhang, Pan Tang, Ling Zou, Jin Zhang, Juncheng Chen, Chengcan Yang, Gu He, Bo Liu, Jie Liu, Cheng-Ming Chiang, Guan Wang, Tinghong Ye, Liang Ouyang
Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy. Journal of medicinal chemistry 64 (24) (2021)
Jinghong Xian, Faqian Bu, Yuxi Wang, Fangyi Long, Zhixiong Zhang, Chengyong Wu, Yiran Tao, Ting Wang, Guan Wang
A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin. Molecules (Basel, Switzerland) 26 (4) (2021)
Jia Li, Guan Wang, Yu Qin, Xue Zhang, Hai-Feng Wang, Hong-Wei Liu, Ling-Juan Zhu, Xin-Sheng Yao
Neuroprotective constituents from the aerial parts of Cannabis sativa L. subsp. sativa . RSC advances 10 (53) (2020)